Financial Architects (New Jersey)’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Financial Architects (New Jersey)’s Portfolio MBVX Stock Details MBVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2	Closed	–	–	1581
2018 Q2	$0	Hold	2	–	–	﹤0.01%	1594
2018 Q1	$0	Buy	+2	New	+$4	﹤0.01%	1664

Other funds holding MBVX

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Financial Architects (New Jersey)'s MBVX Position: Q3 2018 in Review

Financial Architects (New Jersey) sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q3 2018, closing a stake of 2 shares.

Financial Architects (New Jersey) first reported a position in MBVX in Q1 2018 and held it in 2 quarters. The position peaked at $0 in Q2 2018. 2 funds tracked by Wall St. Rank hold MBVX as of Q3 2018.

Financial Architects (New Jersey) reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q3 2018 after selling out during the quarter.
Financial Architects (New Jersey) sold 2 MABVAX THERAPEUTICS HLDGS INC shares in Q3 2018.
Financial Architects (New Jersey) first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q1 2018 and held it in 2 quarters.
Financial Architects (New Jersey)'s MABVAX THERAPEUTICS HLDGS INC position peaked at $0 in Q2 2018.
2 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q3 2018.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2018, filed 29 Oct 2018.